Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Biosimilars Offer Growth Opportunity: President Sakamoto of Toyobo
August 29, 2011
- Revlimid Offers Great Convenience: Dr Hatake of Cancer Institute Hospital
August 29, 2011
- US Court of Appeals Rules for MTPC in Argatroban Patent Dispute
August 29, 2011
- No. of Health Insurance Societies That Report Savings by Generics to Insured More Than Triples: Kenporen
August 29, 2011
- Launching of Novel Anticoagulants Welcomed: JCS Symposium
August 29, 2011
- Radioactive Cesium Detected from RDF Incineration Ashes at Chugai's Research Lab
August 29, 2011
- St. Marianna Univ. Hospital Group Saves over ¥600 Mil. in Drug Expenditures by Using Generics
August 29, 2011
- Takeda to Increase No. of MRs to 2,000 in China
August 29, 2011
- Concrete Disclosure Standards Should Have Been Included in JPMA's GLs for COI: Prof. Miyata
August 29, 2011
- Eisai Subsidiary's CT Colonography System Receives Approval in Japan
August 29, 2011
- Top-100 Product Ranking Affected by Premium, Price Revisions
August 15, 2011
- RoACTEMRA Approved for sJIA in Children 2 Years or Older in Europe
August 15, 2011
- Tella Announces Research Results for Dendritic Cell Vaccine Therapy
August 15, 2011
- Aricept Has Overwhelming Advantage in AD Market in Japan: Mr Honda
August 15, 2011
- Roche's Tarceva Receives Positive Opinion from CHMP for 1st-Line NSCLC Therapy
August 15, 2011
- Korosho Starts Inviting Requests for Approval of Unapproved Drugs/Indications
August 15, 2011
- Yakult Gains Option Rights to Anticancer Drug from Proacta
August 15, 2011
- EC Approves Acquisition of Nycomed by Takeda
August 15, 2011
- First Aid for Choking
August 15, 2011
- Bayer Obtains Exclusive License for Novel Antibiotic
August 15, 2011
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…